Wong, Kathy C. K.
Ismail, Huda S.
Connelly, Kim A.
Verma, Subodh
Ng, Ming-Yen
Deva, Djeven P.
Yan, Andrew T. http://orcid.org/0000-0002-2063-7485
Jimenez-Juan, Laura
Funding for this research was provided by:
AstraZeneca Canada
Article History
Received: 7 July 2023
Accepted: 18 August 2023
First Online: 10 September 2023
Declarations
:
: <i>Dr KCK Wong</i>, no conflicts. <i>Dr HS Ismail</i>, no conflicts. <i>Dr KA Connelly</i> holds the Keenan Chair in Research Leadership at Unity Health Toronto, University of Toronto and reports receiving research grants to his institution from AstraZeneca and Boehringer Ingelheim, support for travel to scientific meeting from Boehringer Ingelheim and honoraria for speaking engagements and ad hoc participation in advisory boards from AstraZeneca, Boehringer Ingelheim and Janssen. <i>Dr S Verma</i> reports receiving research grant support and/or speaking honoraria from Amarin, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Canadian Medical and Surgical Knowledge Translation Research Group, Eli Lilly, HLS Therapeutics, Janssen, Merck, Novartis, Novo Nordisk, Pfizer, PhaseBio, Sanofi, and S&L Solutions. Dr Verma is the President of the Canadian Medical and Surgical Knowledge Translation Research Group, a federally incorporated not-for-profit physician organization <i>Dr MY Ng</i> reports receiving research grant support and/or speaking/consulting honoraria from Circle, Bayer, TeraRecon, GE and Boehringer Ingelheim. <i>Dr DP Deva</i>, no conflicts. <i>Dr AT Yan</i> reports receiving research grant support from AstraZeneca. <i>Dr Laura Jimenez-Juan</i>, no conflicts.
: The study was approved by St. Michael’s Hospital Research Ethics Board.
: All participants were consented to participate. Study team ensured that participants were made aware that participation or lack thereof will have no impact on clinical care provided.
: Waived.